We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

228 hedge funds and large institutions have $833M invested in Myriad Genetics in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

402% more call options, than puts

Call options by funds: $854K | Put options by funds: $170K

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

3% more funds holding

Funds holding: 221 → 228 (+7)

1.26% more ownership

Funds ownership: 101.59% → 102.85% (+1.3%)

0% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 79

34% less capital invested

Capital invested by funds: $1.27B → $833M (-$436M)

Holders
228
Holders Change
+7
Holders Change %
+3.17%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
79
Reduced
79
Closed
29
Calls
$854K
Puts
$170K
Net Calls
+$684K
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$26.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.36M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.44M
4
PCM
Portolan Capital Management
Massachusetts
+$6.6M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$17M
2
CCM
Camber Capital Management
Massachusetts
-$9.01M
3
Artisan Partners
Artisan Partners
Wisconsin
-$5.88M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
-$5.6M
5
BlackRock
BlackRock
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
176
Crewe Advisors
Utah
$8.87K – – –
SHIM
177
Stone House Investment Management
Pennsylvania
$8.87K +$12K +1,000 New
Group One Trading
178
Group One Trading
Illinois
$8.8K +$11.9K +992 New
Ohio Public Employees Retirement System (OPERS)
179
Ohio Public Employees Retirement System (OPERS)
Ohio
$7.85K +$2.02K +168 +23%
US Bancorp
180
US Bancorp
Minnesota
$7.06K +$6.28K +523 +192%
Jones Financial Companies
181
Jones Financial Companies
Missouri
$5.65K -$11.5K -954 -60%
TWD
182
True Wealth Design
Ohio
$5.3K +$5.76K +480 +407%
IBOK
183
Independence Bank of Kentucky
Kentucky
$5.17K – – –
GI
184
GAMMA Investing
California
$4.47K -$2.59K -216 -30%
HI
185
Harbour Investments
Wisconsin
$4.43K +$6K +500 New
SAM
186
Smartleaf Asset Management
Massachusetts
$3.75K -$8.19K -682 -62%
AF
187
Allworth Financial
California
$2.74K -$300 -25 -6%
MWA
188
Medallion Wealth Advisors
Connecticut
$2.66K – – –
CIAM
189
Caitong International Asset Management
Hong Kong
$2.62K +$3.54K +295 New
DWS
190
Dynamic Wealth Strategies
California
$2.45K +$3.31K +276 New
LC
191
Lindbrook Capital
California
$2.14K +$1.47K +122 +103%
WWM
192
Wolff Wiese Magana
California
$2.03K -$5K -416 -64%
EWA
193
EverSource Wealth Advisors
Alabama
$1.7K -$1.98K -165 -46%
VCM
194
Versant Capital Management
Arizona
$1.64K -$14.4K -1,199 -87%
SSG
195
Summit Securities Group
New York
$1.6K +$2.17K +181 New
GIA
196
GHP Investment Advisors
Colorado
$1.55K – – –
WT
197
Washington Trust
Rhode Island
$1.46K +$108 +9 +6%
IA
198
IFP Advisors
Florida
$1.46K +$1.84K +153 +1,391%
BIG
199
Brooklyn Investment Group
New York
$1.43K -$3.62K -301 -65%
HCP
200
Hexagon Capital Partners
Arkansas
$1.39K +$228 +19 +14%
6 7
8
9 10

MYGN Hedge Fund Activity: Q1 2025 in Review

228 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2025, worth a combined $833M — down 34% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MYGN positions and 29 closed out — a net gain of 8 holders — while 79 added to existing stakes and 79 trimmed.

The largest buyer was Disciplined Growth Investors, adding an estimated $26.1M. The largest seller was Wellington Management Group, cutting an estimated $17M.

  • 228 institutional investors held Myriad Genetics (MYGN) as of Q1 2025, up from 221 in Q4 2024.
  • Funds reported $833M of Myriad Genetics stock for Q1 2025, down 34% quarter-over-quarter.
  • 37 funds opened new Myriad Genetics positions in Q1 2025 and 29 closed out, a net change of +8 holders.
  • The largest Myriad Genetics buyer in Q1 2025 was Disciplined Growth Investors, an estimated $26.1M added.
  • The largest Myriad Genetics seller in Q1 2025 was Wellington Management Group, an estimated $17M sold.

Based on aggregated 13F filings for Q1 2025.